Plan your launch around what patients need
PatientlyIQ shows commercial teams what patients and caregivers say about your indication, your product, and its competitors. Use it to plan a launch, shape your messaging, and see when the conversation shifts.
Top patient needs
- Help with insurance
- Managing side effects
- Getting to a specialist
Brand sentiment
+21%
More mentions since last month
- Your brand Positive
- Competitor A Negative
What you get
Launch plans from patient needs
Personas, journey hurdles, and search data shape who you reach, where, and with which message.
Messaging in patients’ words
Branding and copy built from the words patients and caregivers use for their condition and treatments.
Product and competitor monitoring
See how patients talk about your product and its competitors, and the reasons they give.
Early warning
Recurring reports show what changed since last month and where to focus next.
Line 1
Background therapy
| Drug | Approval | Class | Mentions | Sentiment | Top emotions |
|---|---|---|---|---|---|
Hydroxychloroquine (Plaquenil) | Approved | Antimalarial (immunomodulator) | 80 | Disappointment Hope Anxiety | |
ACE inhibitors / ARBs | n/a | ACE inhibitor / ARB (renin-angiotensin blocker) | 6 | Hope Pessimism Curiosity |
Line 2
Induction therapy for active nephritis
| Drug | Approval | Class | Mentions | Sentiment | Top emotions |
|---|---|---|---|---|---|
Corticosteroids (prednisone) | Approved | Corticosteroid | 140 | Disappointment Hope Sadness | |
Mycophenolate (CellCept / Myfortic) | Approved | Antimetabolite (IMPDH / purine inhibitor) | 105 | Acceptance Hope Apprehension | |
Cyclophosphamide (Cytoxan) | Approved | Alkylating agent | 25 | Hope Acceptance Disappointment | |
Belimumab (Benlysta) | Approved | Anti-BLyS / BAFF monoclonal antibody | 135 | Disappointment Hope Anxiety | |
Voclosporin (Lupkynis) | Approved | Calcineurin inhibitor | 7 | Optimism Hope Curiosity |
Line 3
Maintenance, refractory options, and advanced care
| Drug | Approval | Class | Mentions | Sentiment | Top emotions |
|---|---|---|---|---|---|
Azathioprine (Imuran) | Approved | Antimetabolite (IMPDH / purine inhibitor) | 25 | Disappointment Serenity Sadness | |
Rituximab (Rituxan) | Approved | Anti-CD20 monoclonal antibody | 19 | Optimism Anticipation Anxiety | |
Anifrolumab (Saphnelo) | Approved | Type-I interferon receptor antagonist | 43 | Disappointment Optimism Hope | |
Obinutuzumab (Gazyva) | Investigational | Anti-CD20 monoclonal antibody | 2 | Disappointment Hope | |
CAR-T therapy (investigational) | Investigational | Autologous CAR T-cell therapy | 105 | Hope Optimism Anticipation | |
Dialysis or kidney transplant | n/a | n/a | 23 | Despair Hope Confusion |
How it works
1.0
Map the market
We list the treatments, competitors, and patient communities in your indication.
2.0
Listen and tag
Patient conversations are tagged by theme, sentiment, treatment, and journey stage.
3.0
Plan and track
You get personas and messaging themes, then recurring reports on what changed.
Questions it answers
- What do patients need from a new treatment at each stage of care?
- Which words do patients use for their condition and its treatments?
- How do patients feel about your product compared with its competitors?
- Which concerns, such as cost or access, could slow uptake?
Common questions
How we work, in detailFrom public patient and caregiver conversations on social media, patient communities such as PatientsLikeMe and Inspire, advocacy webinars and publications, and patient videos and podcasts. We also read search trends, competitor activity, and peer-reviewed research.
Yes. Upload patient, nurse, or site-staff interviews as audio or text. PatientlyIQ removes identifying details, splits each answer into quotes, and tags them the same way as the rest of the data.
With its theme, its sentiment, and the stage of the patient journey it describes. You can search and filter by all three.
Names and other identifying details are removed before a quote can be searched. The meaning of the quote stays.
Recurring executive reports every 30, 60, or 90 days, bespoke reports on a single question, or both. Your team can also search the quotes and export charts in the platform.
A bespoke report typically takes 12 to 20 business days from project confirmation, depending on scope.
Recurring reports are priced per month and bespoke reports per report. We agree the indication, topics, and measures with you first.
Related use cases
See PatientlyIQ on your indication
We will walk you through what patients and caregivers are saying in your therapeutic area.